Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease

di Abdul Razak, Albiruni Ryan, Li, Louise, Bryant, Andrew, Diaz-Padilla, Ivan
Pubblicazione 2011

Estimation of expectedness: Predictive accuracy of standard therapy outcomes in randomized phase 3 studies in epithelial ovarian cancer

di Castonguay, Vincent, Wilson, Michelle K., Diaz‐Padilla, Ivan, Wang, Lisa, Oza, Amit M.
Pubblicato in Cancer (2014)

Safety and tolerance of enteral nutrition in COVID-19 critically ill patients, a retrospective study

di Osuna-Padilla, Iván, Rodríguez-Moguel, Nadia Carolina, Aguilar-Vargas, Adriana, Rodríguez-Llamazares, Sebastián
Pubblicato in Clin Nutr ESPEN (2021)

Borderline tumours of the ovary, current controversies regarding their diagnosis and treatment

di Patrono, María Guadalupe, Minig, Lucas, Diaz-Padilla, Ivan, Romero, Nuria, Rodriguez Moreno, Juan Francisco, Garcia-Donas, Jesus
Pubblicazione 2013

Fatal respiratory disease due to a homozygous intronic ABCA3 mutation: a case report

di Pachajoa, Harry, Ruiz-Botero, Felipe, Meza-Escobar, Luis Enrique, Villota-Delgado, Vania Alexandra, Ballesteros, Adriana, Padilla, Ivan, Duarte, Diana
Pubblicato in J Med Case Rep (2016)

Alcohol and tobacco consumption concordance and its correlates in older couples in Latin America

di Machado, Mayra Pires Alves, Opaleye, Davi Camara, Pereira, Tiago Veiga, Padilla, Ivan, Noto, Ana Regina, Prince, Martin, Ferri, Cleusa Pinheiro
Pubblicato in Geriatr Gerontol Int (2017)

A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours

di van Bussel, Mark T. J., Awada, Ahmad, de Jonge, Maja J. A., Mau-Sørensen, Morten, Nielsen, Dorte, Schöffski, Patrick, Verheul, Henk M. W., Sarholz, Barbara, Berghoff, Karin, El Bawab, Samer, Kuipers, Mirjam, Damstrup, Lars, Diaz-Padilla, Ivan, Schellens, Jan H. M.
Pubblicato in Br J Cancer (2020)

A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041)

di Chiu, Joanne W., Hotte, Sebastien J., Kollmannsberger, Christian K., Renouf, Daniel J., Cescon, David W., Hedley, David, Chow, Sue, Moscow, Jeffrey, Chen, Zhuo, Perry, Meghan, Diaz-Padilla, Ivan, Tan, David, Hirte, Hal, McWhirter, Elaine, Chen, Helen, Siu, Lillian L., Bedard, Philippe L.
Pubblicato in Invest New Drugs (2015)

A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors

di Diaz-Padilla, Ivan, Hirte, Hal, Oza, Amit M., Clarke, Blaise A., Cohen, Brenda, Reedjik, Michael, Zhang, Tong, Kamel-Reid, Suzanne, Ivy, S. Percy, Hotte, Sebastien J., Razak, Albiruni A. R., Chen, Eric X., Brana, Irene, Wizemann, Monika, Wang, Lisa, Siu, Lillian L., Bedard, Philippe L.
Pubblicazione 2013

A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB)

di Mayer, Ingrid A., Prat, Aleix, Egle, Daniel, Blau, Sibel, Perez Fidalgo, J. Alejandro, Gnant, Michael, Fasching, Peter A., Colleoni, Marco, Wolff, Antonio C., Winer, Eric P., Singer, Christian F., Hurvitz, Sara, Estevez, Laura Garcia, van Dam, Peter A., Kümmel, Sherko, Mundhenke, Christoph, Holmes, Frankie, Babbar, Naveen, Charbonnier, Laure, Diaz-Padilla, Ivan, Vogl, Florian D., Sellami, Dalila, Arteaga, Carlos L.
Pubblicato in Clin Cancer Res (2019)

Ovarian Cancer

Pubblicazione 2013